Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?
Summary
Ovarian Cancer (OC), the deadliest gynecological malignancy, poses a major therapeutic challenge in advanced stages owing to its high recurrence rate and metast...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.